Exact Mass: 253.01889179999998

Exact Mass Matches: 253.01889179999998

Found 372 metabolites which its exact mass value is equals to given mass value 253.01889179999998, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Sulfamethoxazole

4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzene-1-sulfonamide

C10H11N3O3S (253.0521096)

Sulfamethoxazole is only found in individuals that have used or taken this drug. It is a bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)Sulfonamides inhibit the enzymatic conversion of pteridine and p-aminobenzoic acid (PABA) to dihydropteroic acid by competing with PABA for binding to dihydrofolate synthetase, an intermediate of tetrahydrofolic acid (THF) synthesis. THF is required for the synthesis of purines and dTMP and inhibition of its synthesis inhibits bacterial growth. Pyrimethamine and trimethoprim inhibit dihydrofolate reductase, another step in THF synthesis, and therefore act synergistically with the sulfonamides. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01EC - Intermediate-acting sulfonamides COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides CONFIDENCE standard compound; EAWAG_UCHEM_ID 298 CONFIDENCE standard compound; INTERNAL_ID 1018 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Tizanidine

5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine

C9H8ClN5S (253.01889179999998)

Tizanidine is a short-acting drug for the management of spasticity. Tizanidine is an agonist at a2-adrenergic receptor sites and presumably reduces spasticity by increasing presynaptic inhibition of motor neurons. In animal models, tizanidine has no direct effect on skeletal muscle fibers or the neuromuscular junction, and no major effect on monosynaptic spinal reflexes. The effects of tizanidine are greatest on polysynaptic pathways. The overall effect of these actions is thought to reduce facilitation of spinal motor neurons. Tizanidine has two major metabolites: (1) 5-chloro-4-(2-imidazolin-4-on-2-ylamino)-2,1,3-benzothiazdiazole and (2) 5-chloro-4-(2-imidazolin-4-on-2-ylamino)-2,1,3-benzothiadiazole (PMID: 9929503, 19961320). M - Musculo-skeletal system > M03 - Muscle relaxants > M03B - Muscle relaxants, centrally acting agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002491 - Central Nervous System Agents > D000700 - Analgesics Tizanidine is an α2-adrenergic receptor agonist and inhibits neurotransmitter release from CNS noradrenergic neurons. Target: α2-adrenergic receptor Tizanidine is a drug that is used as a muscle relaxant. It is a centrally acting α2 adrenergic agonist. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, ALS, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia. Tizanidine has been found to be as effective as other antispasmodic drugs and has superior tolerability to that of baclofen and diazepam. Tizanidine can be very strong even at the 2 mg dose and may cause hypotension, so caution is advised when it is used in patients who have a history of orthostatic hypotension, or when switching from gel cap to tablet form and vice versa. Tizanidine can occasionally cause liver damage, generally the hepatocellular type. Clinical trials show that up to 5\% of patients treated with tizanidine had elevated liver function test values, though symptoms disappeared upon withdrawal of the drug. Care should be used when first beginning treatment with tizanidine with regular liver tests for the first 6 months of treatment.

Chloridazon catechol

5-Amino-4-chloro-2-(2,3-dihydroxyphenyl)-3(2H)-pyridazinone

C10H8ClN3O3 (253.0254168)

SCHEMBL4930838

5-[(Z)-3-carboxy-3-oxoprop-1-enyl]-4-hydroxy-6-oxo-1H-pyridine-2-carboxylic acid

C10H7NO7 (253.0222512)

N-Pyruvoyl-5-methoxy-3-hydroxyanthranilate

N-Pyruvoyl-5-methoxy-3-hydroxyanthranilic acid

C11H11NO6 (253.0586346)

Furothiazole

N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide

C9H7N3O4S (253.0157262)

N-Salicyloylaspartic acid

2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}butanedioate

C11H11NO6 (253.0586346)

Constituent of kidney beans (Phaseolus vulgaris) and grape (Vitis subspecies). N-Salicyloylaspartic acid is found in many foods, some of which are green bean, yellow wax bean, pulses, and fruits. N-Salicyloylaspartic acid is found in fruits. N-Salicyloylaspartic acid is a constituent of kidney beans (Phaseolus vulgaris) and grape (Vitis species).

2-(1,2,3,4-Tetrahydroxybutyl)thiazolidine-4-carboxylic acid

D-Ribo-2-(1,2,3,4-tetrahydroxybutyl)thiazolidine-4-carboxylic acid

C8H15NO6S (253.062005)

1-Naphthalenesulfonic acid, 4-hydroxy-3-nitroso-

C10H7NO5S (253.00449319999998)

Deferitrin

(2Z,4S)-2-(2-hydroxy-4-oxocyclohexa-2,5-dien-1-ylidene)-4-methyl-1,3-thiazolidine-4-carboxylic acid

C11H11NO4S (253.0408766)

[(2R,3R,4R)-3,4,5-Trihydroxy-1-oxopentan-2-yl] (2R)-2-amino-3-sulfanylpropanoate

[(2R,3R,4R)-3,4,5-Trihydroxy-1-oxopentan-2-yl] (2R)-2-amino-3-sulphanylpropanoic acid

C8H15NO6S (253.062005)

Methylmercury chloride